Skip to main content

Table 5 Model-based age-adjusted 5-year relative survival in 2002 and 2006 by histology and stage for endometrial cancer patients diagnosed in Germany, 1997-2006

From: Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage

Histology Stagea 2002 (1) 2006 (2) Change of RS
(2)-(1)
P-valueb
   Count RS (SE) Count RS (SE)   
Adenocarcinoma   3,511 82.6 (0.7) 3,495 84.5 (0.6) 1.9 0.066
Adenocarcinoma, NOS   1,526 84.7 (1.0) 700 84.3 (1.1) -0.3 0.848
Papillary/clear cellc   322 67.0 (2.7) 186 68.9 (2.6) 1.9 0.643
Mucinous/squamous/
adenosquamous
  228 80.5 (3.2) 157 85.2 (2.5) 4.7 0.265
Endometrioid   1,435 85.7 (0.9) 2,452 85.8 (0.9) 0.1 0.961
Sarcoma   199 48.6 (2.6) 223 39.7 (2.6) -8.9 0.048
Others (mixture) d   93 55.8 (4.1) 91 54.1 (4.1) -1.7 0.789
All Localized 1,409 90.5 (1.0) 1,497 91.8 (0.9) 1.3 0.362
  Regional 91 47.0 (4.2) 137 53.3 (4.0) 6.3 0.368
  Distant 116 19.4 (2.8) 146 21.4 (2.9) 2.0 0.641
  Overall 1,616 82.8 (0.9) 1,780 83.4 (0.9) 0.5 0.721
  1. Abbreviations: NOS = not otherwise specified; RS = point estimate of relative survival (%); SE = standard error (percent units);
  2. a restricted to cases with complete stage information;
  3. b the differences between RS (percent units) were tested using model-based period analysis;
  4. c including other adenocarcinoma;
  5. d including carcinoma NOS.